Literature DB >> 22189112

Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii.

Kuei-Hsiang Hung1, Ming-Cheng Wang, Ay-Huey Huang, Jing-Jou Yan, Jiunn-Jong Wu.   

Abstract

Heteroresistance to antimicrobial agents may affect susceptibility test results and therapeutic success. In this study, we investigated heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii, a major pathogen causing nosocomial infections. Two A. baumannii isolates exhibited heteroresistance to ampicillin-sulbactam, ticarcillin-clavulanic acid, cefepime, and cefpirome, showing a distinct colony morphology of circular rings within the inhibition halos. Pulsed-field gel electrophoresis (PFGE) and outer membrane protein (OMP) analysis demonstrated that subpopulations around the disks/Etest strips and the original strains all belonged to the same PFGE type and OMP profile. Population analysis profile (PAP) showed the presence of heteroresistant subpopulations with high cefepime resistance levels in two isolates (008 and 328). Interestingly, A. baumannii 008 contained two peaks: one was grown in the presence of up to 1 μg of cefepime/ml, the other apparently occurred when the concentration of cefepime was raised to 256 μg/ml. After serial passages without exposure to cefepime, the PAP curve maintained the same trend observed for the original strain of A. baumannii 008. However, the PAP curve showed a shift to relatively lower cefepime resistance (from 256 to 64 μg/ml) in A. baumannii 328 after 10 passages in antibiotic-free Mueller-Hinton agar plates. Convergence to a monotypic resistance phenotype did not occur. Growth rate analysis revealed that slower growth in resistant subpopulations may provide a strategy against antibiotic challenge. To our knowledge, this is the first report of heteroresistance to cephalosporins and penicillins in A. baumannii.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189112      PMCID: PMC3295183          DOI: 10.1128/JCM.05085-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Heteroresistance to vancomycin in Enterococcus faecium.

Authors:  M R Alam; S Donabedian; W Brown; J Gordon; J W Chow; M J Zervos; E Hershberger
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Hetero-resistance: an under-recognised confounder in diagnosis and therapy?

Authors: 
Journal:  J Med Microbiol       Date:  2001-12       Impact factor: 2.472

Review 3.  Treatment of Acinetobacter infections.

Authors:  Joel Fishbain; Anton Y Peleg
Journal:  Clin Infect Dis       Date:  2010-07-01       Impact factor: 9.079

4.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Two Streptomycin-resistant Variants of Meningococcus.

Authors:  C P Miller; M Bohnhoff
Journal:  J Bacteriol       Date:  1947-10       Impact factor: 3.490

Review 6.  Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.

Authors:  Nicola C Gordon; David W Wareham
Journal:  Int J Antimicrob Agents       Date:  2010-01-04       Impact factor: 5.283

Review 7.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

8.  OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan.

Authors:  Jing-Jou Yan; Shu-Huei Tsai; Chin-Luan Chuang; Jiunn-Jong Wu
Journal:  J Microbiol Immunol Infect       Date:  2006-04       Impact factor: 4.399

9.  Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii.

Authors:  Felipe Fernández-Cuenca; Luis Martínez-Martínez; Maria Carmen Conejo; Juan A Ayala; Evelio J Perea; Alvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

10.  Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii.

Authors:  Alexandros Ikonomidis; Evangelia Neou; Vassiliki Gogou; Georgia Vrioni; Athanassios Tsakris; Spyros Pournaras
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

View more
  16 in total

1.  Population analysis of Escherichia coli isolates with discordant resistance levels by piperacillin-tazobactam broth microdilution and agar dilution testing.

Authors:  Carole Shubert; Jen Slaughter; David Creely; Alex van Belkum; Jean Pierre Gayral; William Michael Dunne; Gilles Zambardi; Dee Shortridge
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

Review 2.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

Authors:  Sheila Adams-Sapper; Shantell Nolen; Grace Fox Donzelli; Mallika Lal; Kunihiko Chen; Livia Helena Justo da Silva; Beatriz M Moreira; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

Review 4.  Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.

Authors:  Fereshteh Ezadi; Abdollah Ardebili; Reza Mirnejad
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

5.  International dissemination of Escherichia coli strains with discrepant behaviour in phenotypic antimicrobial susceptibility tests.

Authors:  D Creely; G Zambardi; A van Belkum; Wm M Dunne; M Peyret; J P Gayral; D Shortridge; C Shubert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-09       Impact factor: 3.267

Review 6.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  Colistin heteroresistance in Enterobacter cloacae is regulated by PhoPQ-dependent 4-amino-4-deoxy-l-arabinose addition to lipid A.

Authors:  Katie N Kang; Dustin R Klein; Misha I Kazi; François Guérin; Vincent Cattoir; Jennifer S Brodbelt; Joseph M Boll
Journal:  Mol Microbiol       Date:  2019-04-10       Impact factor: 3.501

8.  A low-affinity penicillin-binding protein 2x variant is required for heteroresistance in Streptococcus pneumoniae.

Authors:  Hansjürg Engel; Moana Mika; Dalia Denapaite; Regine Hakenbeck; Kathrin Mühlemann; Manfred Heller; Lucy J Hathaway; Markus Hilty
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

9.  Epidemiological and clinical features for cefepime heteroresistant Escherichia coli infections in Southwest China.

Authors:  W Ma; J Sun; S Yang; L Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-27       Impact factor: 3.267

10.  Heteroresistance to fosfomycin is predominant in Streptococcus pneumoniae and depends on the murA1 gene.

Authors:  Hansjürg Engel; Javier Gutiérrez-Fernández; Christine Flückiger; Martín Martínez-Ripoll; Kathrin Mühlemann; Juan A Hermoso; Markus Hilty; Lucy J Hathaway
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.